Shanghai Junshi Biosciences Co., Ltd. (1877.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap19.27B
Enterprise Value20.79B
P/E Ratio-46.71
PEG Ratio-0.64
Price/Sales Ratio11.35
Price/Book Ratio5.28
Enterprise/Revenue12.11
Enterprise/EBITDA-57.78

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.24
Operating Margin-0.3
AD

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.11

Income Statement

Revenue2.43B
Revenue/Share2.66
Gross Profit1.97B
EBITDA-599.38M
Net Income-851.76M
Diluted EPS-0.84

Balance Sheet

Total Cash4.55B
Total Cash/Share4.45
Total Debt5.96B
Total Debt/Equity1.01
Current Ratio2.14
Book Value Per Share5.94

Price History

52-Week Change-26.35
52-Week High38.64
52-Week Low15.44
Moving Average 50 Days22.7
Moving Average 200 Days24.16

Statistics

Average Volume4.19M
Shares Outstanding1.41B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.11
Last Split FactorN/A
Last Split DateN/A
AD